Insider Trading & Ownership of BridgeBio Pharma LLC

Location
Palo Alto, CA
Summary
The estimated value of insider holdings of BridgeBio Pharma LLC is at least $156,363,757 dollars as of 16 Oct 2025. BridgeBio Pharma LLC is the 10%+ Owner of BridgeBio Oncology Therapeutics, Inc. and owns shares of Helix Acquisition Corp. II (HLXB) stock worth about $156,363,757.
Signature
/s/ Neil Kumar, Chief Executive Officer of BridgeBio Pharma LLC
All Insider Reports
All Insider Reports

Notify me when BridgeBio Pharma LLC files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of BridgeBio Pharma LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HLXB Helix Acquisition Corp. II 10%+ Owner $156,363,757 10 Oct 2025

Insider Transactions Reported by BridgeBio Pharma LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.